Men at a higher risk, including Black men and those who had a brother or father diagnosed with cancer before age 65, should ask their care team about testing at age 45

The REVOLUTION study, Diabetes Epidemiology and Management (2024) Efficacy of semaglutide in a subcutaneous and oral formulation, Frontiers in Endocrinology (2021) Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial, Nature Medicine (2022) Real-world use of oral versus subcutaneous semaglutide in a cohort of Type 2 diabetic patients: which option to which patient?, Journal of Endocrinological Investigation (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, FDA.gov (2024) Dietary supplements for weight loss, National Institutes of Health Evaluation of efficacy and safety of orlistat in obese patients, Indian Journal of Endocrinology and Metabolism (2011) A systematic review of dietary supplements and alternative therapies for weight loss, Obesity (2021) Are weight loss supplements safe?, Poison Control Tainted weight loss products, FDA.gov Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

The seven-day half-life is a property of the semaglutide molecule itself, not the packaging or brand
otherwise, additional contraception is needed for seven days
When to Adjust Your Wegovy Dose or Get a Prescription for Wegovy Adjusting your Wegovy dose or obtaining a prescription should be based on your individual response to the medication and any side effects you experience